Meridian Bioscience (VIVO) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $4.59 --0%
Financial Fact:
BASIC EARNINGS PER COMMON SHARE: 0.13
Today's EPS Names:
EGRX, MOVE, MDRX, More
Financial Fact:
BASIC EARNINGS PER COMMON SHARE: 0.13
Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q1 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $47.2 million versus the consensus estimate of $48.6 million.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
- Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
